Lauren Stival Hopfer

Lauren Stival Hopfer is an experienced professional in investor relations, currently serving as the Executive Director of Investor Relations at enGene since July 2025. Previously, Lauren held the position of Senior Vice President at Kendall Investor Relations, LLC from December 2022 to July 2025, and served in various roles including Investor Relations at Sporos Bioventures and Senior Director of Investor Relations at Dicerna Pharmaceuticals, Inc. Lauren's background also includes leadership positions at Stern Investor Relations, Avadel Pharmaceuticals plc, ICR, Thomson Reuters, and Gleacher & Company, as well as an early role as an Investment Banking Analyst at MD Global Partners. Lauren holds a Bachelor of Arts from Duke University and an MBA from The Fuqua School of Business, and graduated from Blair Academy.